Introduction
A series of recent publications has highlighted the importance of changing patterns of donor/recipient chimerism kinetics in the evolution of both relapse and rejection. [1] [2] [3] [4] [5] [6] [7] Yet it remains difficult to define consistent patterns between these various reports. In part this may result from the use of differing methods of analysis (and inherent sensitivity) between centres and inconsistency between the times after transplant at which analyses are performed. Further diversity is added by the range of conditions transplanted, and conditioning protocols and regimens of GVHD prophylaxis employed.
The editors of Leukemia have therefore sought to standardise the technological approaches used and to provide a framework for the comparison of diagnostic results through their Round-Table Debate on chimerism, which began in 1999. 8 As part of this continuing debate, 9, 10 we present technical details of the assay developed in our laboratory for quantitative analysis of chimerism.
I. Assay characteristics
The methodology outlined here is based on the assay originally developed by Lawler et al, in 1989 and 1991 . 1, 11 However, such methods often fail when cell counts are too low to enable conventional DNA extraction. This precludes the study of engraftment during critical periods such as suspected rejection or primary non-engraftment. We therefore combined microsatellite PCR with immunomagnetic selection, eg use of a combination anti-CD15 and anti-CD45 conjugated magnetic beads to capture most leukocytes. This has allowed consistent determination of chimeric status from profoundly leukopenic peripheral blood samples (WBC is Ͻ0.1 × 10 9 /l).
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The quantitative component of the assay was established according to the technique outlined by Bader et al, in 1996 and 1999. 13,14 Using this approach, quantitation is achieved by comparison with standard curves generated for each patient following PCR amplification of known dilutions of donor and recipient DNA. Accurate quantitation is ensured by virtue of the competitive nature of the PCR. 15 This has become yet more practical with the introduction of fluorescent PCR primers and analysis of products on a genetic ana- lyser. This approach to the fluorescent analysis of chimerism is outlined in detail in this contribution. Brief details of the non-fluorescent method are also included for the benefit of laboratories that do not have access to either a DNA sequencer or genetic analyser.
II. Protocol

Template preparation (a) Preparation of donor and recipient control samples:
DNA extraction using QIAamp DNA mini kits (Qiagen Ltd, Crawley, UK) is recommended. This method ensures the purification of up to 50 g of DNA from 200 l buffy coat containing 5 × 10 6 cells. Either 1-2 ml of bone marrow or 5-10 ml peripheral blood is obtained from the donor and recipient prior to BMT. Samples are diluted in 5 ml PBS and then layered on to 10 ml Lymphoprep (Nycomed Pharma, Oslo, Norway). Following centrifugation (400 g for 30 min) the mononuclear cell layer is isolated and washed in PBS. DNA is then extracted from a maximum of 5 × 10 6 cells and resuspended in TE buffer (Tris-HCl, pH 8.0, 1 mM EDTA) to a concentration of 100 ng/l. Incubation of all DNA solutions at 37°C prior to use is recommended.
(b) Immunomagnetic selection of post-transplant samples:
Samples for the analysis of post-transplant chimerism are prepared by immunomagnetic selection using magnetic beads directly conjugated to anti-CD15 and anti-CD45 monoclonal antibody (Dynal, Oslo, Norway). 1-2 ml of peripheral blood, obtained at various time-points following BMT, are directly incubated with 10 l CD15 and 10 l CD45 Dynabeads and incubated at room temperature on a blood tube rotator for 30 min. Selected cells are then isolated using a magnetic particle concentrator (MPC, Dynal) and washed twice with 0.1% (w/v) BSA/PBS. Prior to PCR, 25 l of 1 × PCR buffer is added to the pellet, overlaid with four drops of light mineral oil (Sigma, Poole, UK) and heated at 90°C for 30 min. 4 l of the resuspended bead/cell mix is used in each 100 l PCR reaction. Once prepared, beaded samples can be stored indefinitely at −20°C.
Microsatellite panel
Details of the microsatellite panel used can be found in Table  1 . This panel of microsatellite markers has been used to identify an informative locus in more than 450 allogeneic transplants (121 from sibling donors, 299 from unrelated donors and 33 from haploidentical donors). For fluorescent analysis, 
Capillary/gel electrophoresis (a) Capillary electrophoresis:
Fluorescence analysis is performed on an ABI Prism 310 Genetic Analyser using the POP-4 polymer, 47 cm × 50 m capillaries and 10 × Genetic Analysis buffer with EDTA (Applied Biosystems, Warrington, UK). A 1 l aliquot of PCR product is combined with 12 l deionised formamide and 0.5 l GeneScan 350 (Tamralabelled) size standards. Fluorescent data are collected using the ABI Prism 310 Collection software (version 1.2) and analysed with GeneScan software (version 2.1) (both Applied Biosystems). Samples are denatured at 94°C for 4 min and placed on ice immediately for a minimum of 4 min. Standard electrophoretic parameters (1650 V for 24 min) are employed for the collection of each sample. Different injection times (5, 10 and/or 15 and 20 s) are programmed into the injection list to ensure optimal collection of fluorescent data. The dilution of PCR products in 1 × PCR buffer is recommended if peak heights exceed 5000 fluorescence units.
(b) PAGE electrophoresis:
In the absence of either a DNA sequencer or genetic analyser, PCR products can be resolved by polyacrylamide gel electrophoresis (PAGE). 25 l aliquots of the PCR products containing 3 l of 10 × loading dye (0.25% xylene cyanol, 0.25% bromophenol blue and 50% glycerol) are resolved on 6% non-denaturing polyacrylamide gel (Hoefer SE 600 gel electrophoresis unit; Pharmacia Biotech, St Albans, UK). Gels are electrophoresed at a constant 500 V (starting current 150 mÅ for one gel and 300 mÅ for two gels) with 1 × TBE (89 M Tris, 89 M orthoboric acid, 2 M EDTA) for approximately 1 h. Following electrophoresis gels are stained with 250 ml ethidium bromide solution (10 mg/ml) and the gel image captured electronically using the Gel Doc 1000 gel documentation system and Molecular Analyst Software (both BioRad Laboratories, Hemel Leukemia Hempstead, UK). Densitometric analysis of the gel image is performed using the Molecular Analyst Software.
Quantification of donor chimerism
Quantification of the degree of mixed chimerism is determined by mixing pre-transplant recipient and donor DNA in dilution experiments. Mixes of recipient and donor DNA are then subjected to PCR amplification by one or more information loci.
(a) Preparation of donor/recipient dilution series:
Prior to use, each DNA solution is incubated at 37°C for 30 min to ensure homogeneity. DNA is quantitated by UV spectrophotometry (GeneQuant Pro DNA Calculator, Pharmacia Biotech) and samples then diluted to 10 ng/l. A 50:50 mix of donor: recipient DNA is prepared and incubated at 37°C for 30 min. This solution is then used as the starting point for the creation of two separate serial dilution series: (1) where the 50:50 mix is diluted out in donor DNA, creating 25%, 12.5%, 6.25%, 3.13%, 1.56% and 0.8% recipient DNA dilutions; and (2) where the 50:50 mix is diluted out in recipient DNA, creating 75%, 87.5%, 93.75%, 96.87%, 98.4% and 99.2% recipient DNA dilutions. Two individual dilutions are then prepared: (1) a 37.5% recipient point is created by dilution of the 75% recipient point in an equal volume of donor DNA; and (2) a 62.5% recipient point by dilution of the 25% recipient point (75% donor) in an equal volume of recipient DNA. The combination of the two dilution series and the 62.5% and 37.5% points creates a dilution series that covers 0.8-99.2% recipient DNA dilutions, where the largest increment is 15%. 100 ng of each dilution point is then subjected to PCR amplification according to the method described above. Mixing experiments are carried out in duplicate and standard curves are generated from the mean values.
(b) Generation of standard curves:
Following electrophoresis, donor and recipient alleles are identified according to their respective size. Peak heights and areas for each allele are recorded. Although both can be used, it is recommended that peak areas rather than peak heights be used in all calculations. The proportion of recipient DNA is expressed according to the following quotient: % Recipient = (A R1 + A R2 )/(A R1 + A R2 + (A D1 + A D2 ), where A is peak area, D is donor allele(s) and R is recipient allele(s). If alleles are shared between the donor and recipient then these are not included in the calculation.
Standard curves are generated by plotting the respective R/D quotient value against the percentage of recipient DNA. An example of a standard curve is shown in Figure 1 . All posttransplant samples are investigated in duplicate and mean values calculated. R/D quotients are calculated according to the above formula. The degree of mixed chimerism seen in any post-transplant sample is calculated relative to that particular patient's standard curve.
II. Time requirement
The following timings are all based upon the use of a single capillary ABI Prism 310 Genetic Analyser. The use of a multicapillary instrument (eg an ABI Prism 3100 Genetic Analyser)
Figure 1
Example of standard curve generated following fluorescent PCR amplification of known dilutions of donor and recipient pretransplant DNA using the D3S3045 microsatellite marker. 
IV. Informativeness/specificity
The microsatellite panel shown in Table 1 succeeded in identifying at least one informative marker in over 450 donor/recipient pairs. These comprised 121 from sibling donors, 299 from unrelated donors, and 33 from haploidentical donors where differences between donor and recipient were restricted to a single allele.
It is recommended that microsatellite markers where donor and recipient alleles are separated by only one repeat unit should not be used for quantitative analysis of chimerism. This is due to the presence of stutter or shadow peaks which characteristically exist one repeat shorter than the parent allele with a peak height of Ͻ10%. 16, 17 Such stutter peaks occur as a result of slipped strand mispairing during the amplification of microsatellite loci. 18 Similarly, the presence of a single unique allele, either donor or recipient, has been shown to limit the specificity of the assay. The ideal allelic constellation for the specific and sensitive quantification of chimerism is outlined in section II.2 (microsatellite panel).
V. Sensitivity
The sensitivity of detection of the minor population for each of the microsatellite markers used is influenced by a number of factors, including (a) the size differential between donor and recipient alleles; (b) the numbers of alleles co-amplified; and (c) whether the donor or the recipient alleles are shorter in length. Examination of the allelic constellations shows that maximal sensitivities of 0.8-1.56% are achieved using a microsatellite locus where the recipient has the shortest alleles. Conversely selection of loci where the donor has the shorter allele result in sensitivities of 1.56-6.25%. These discrepancies are less pronounced following fluorescent analysis than after non-fluorescent analysis, probably reflecting the limited linear range of EtBr staining and restrictions of the densitometric analysis. In addition it is possible that the occurrence of heteroduplex bands may also reduce the sensitivity of detection. Importantly, the formation of heteroduplexes is prevented by the denaturation and cooling of PCR products in the presence of deionised formamide prior to fluorescent analysis.
VI. Reproducibility and quality control
The reproducibility of the assay has been assayed using both repeated injections of the same PCR product and repeated amplifications of the different mixtures of DNA. In these studies the peak heights and peak areas were shown to vary by 3-5% and 1-2%, respectively, following repeated injections and by 7-12% and 5-10%, respectively, after reamplification. As a result it is recommended that values peak areas, rather than peak heights be used for the quantification of mixed chimerism.
Ensuring the quality control of the assay is vital. For this reason, all standard curves are created from two individual mixing experiments and the analysis of each time-point is performed in duplicate. A sample from the preceding time-point is also included if the patient has been analysed previously. In addition, a point from the dilution series is included in each analysis. If the R/D quotient for this point is more than 10% outside the mean value obtained from the corresponding standard curve then the assay is repeated. The accuracy of the results can be increased further by performing each analysis with more than one marker.
VII. Cost of the assay
The unit cost of a single fluorescent PCR and its subsequent analysis is 7. These costs are for consumables only and include neither technical time (see section III. Time requirement), the purchase of the instrument nor routine maintenance.
VIII. Troubleshooting
In order to maximise sensitivity of the assay it is essential to inject sufficient PCR product on to the capillary. It is important, however, not to load too much PCR product as this will produce 'topping off' of the peaks and result in inaccurate quantitation. It is recommended therefore that PCR products should be injected with a series of different injection times. If the signal strengths obtained are too high (evidenced by topping off of the major peaks) then the PCR product should be diluted in 1 × PCR buffer prior to reloading.
In contrast to Pindolia et al, 19 we have found that the presence of stutter peaks causes serious problems with both the interpretation and quantitation of chimerism. As discussed earlier, our selection criteria exclude the use of markers where donor and recipient alleles are separated by just one repeat unit. However, the ability to exclude less eligible markers is directly related to the size of the screening panel (our reason for developing the 15 marker screening panel outlined in Table 1 ). All of the primers in our panel amplify tetranucleo-tide repeat markers, since we have found that dinucleotide or trinucleotide repeat markers suffer from excessively high levels of stutter.
